We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$631M
AUM Growth
-$128M
Cap. Flow
-$128M
Cap. Flow %
-20.23%
Top 10 Hldgs %
38.34%
Holding
283
New
100
Increased
32
Reduced
32
Closed
102

Sector Composition

Rank Sector Weight
1 Healthcare 24.53%
2 Technology 13.99%
3 Industrials 12.97%
4 Financials 8.91%
5 Consumer Discretionary 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAZZ icon
1
Jazz Pharmaceuticals
JAZZ
$16.1B
$41.4M 6.57%
253,000
-15,000
-6% -$2.49M
SUNE
2
DELISTED
SUNEDISON, INC COM
SUNE
$31.1M 4.93%
1,593,700
-211,800
-12% -$4.02M
ZBH icon
3
Zimmer Biomet
ZBH
$18.5B
$24.4M 3.88%
221,965
-26,780
-11% -$2.82M
SCTY
4
DELISTED
SolarCity Corporation
SCTY
$23.9M 3.8%
447,600
+247,600
+124% +$13.3M
HASI icon
5
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.95B
$23.7M 3.76%
1,667,810
+326,700
+24% +$4.53M
GILD icon
6
Gilead Sciences
GILD
$167B
$23M 3.65%
244,000
-436,900
-64% -$45.2M
B
7
CALL
Barrick Mining
B
$61.5B
$19.6M 3.11%
+1,822,400
New +$22.5M
BAC icon
8
CALL
Bank of America
BAC
$439B
$19.1M 3.03%
+1,070,000
New +$18.3M
CYH icon
9
Community Health Systems
CYH
$393M
$17.8M 2.82%
+399,300
New +$17.1M
BABA icon
10
Alibaba
BABA
$276B
$17.7M 2.8%
170,000
+200
+0.1% +$20.5K
C icon
11
Citigroup
C
$222B
$16.2M 2.57%
+300,000
New +$15.9M
SUPN icon
12
Supernus Pharmaceuticals
SUPN
$2.77B
$15.7M 2.49%
1,890,000
+75,000
+4% +$630K
FFIV icon
13
F5
FFIV
$22.9B
$14.4M 2.28%
110,000
+3,000
+3% +$374K
ZBH icon
14
CALL
Zimmer Biomet
ZBH
$18.5B
$14.2M 2.25%
128,750
OPCH icon
15
Option Care Health
OPCH
$3.53B
$13.3M 2.11%
475,000
+68,750
+17% +$1.7M
DOC
16
DELISTED
PHYSICIANS REALTY TRUST
DOC
$12.7M 2.01%
765,000
-60,000
-7% -$916K
HDS
17
DELISTED
HD Supply Holdings, Inc.
HDS
$12.7M 2.01%
+429,100
New +$12M
URI icon
18
United Rentals
URI
$67.9B
$12.2M 1.94%
120,000
+5,000
+4% +$536K
SUNE
19
CALL
DELISTED
SUNEDISON, INC COM
SUNE
$10.9M 1.73%
559,800
-440,200
-44% -$8.36M
IRT icon
20
Independence Realty Trust
IRT
$3.93B
$10.2M 1.62%
1,100,000
+425,000
+63% +$4.04M
MTZ icon
21
MasTec
MTZ
$24.7B
$10.2M 1.61%
449,900
-185,100
-29% -$4.58M
VRNT
22
DELISTED
Verint Systems
VRNT
$10.1M 1.59%
338,618
-55,160
-14% -$1.61M
WBMD
23
DELISTED
WebMD Health Corp.
WBMD
$9.74M 1.55%
246,386
-87,677
-26% -$3.37M
BSFT
24
DELISTED
BroadSoft, Inc.
BSFT
$9.07M 1.44%
+312,500
New +$7.9M
RAD
25
DELISTED
Rite Aid Corporation
RAD
$8.72M 1.38%
+58,000
New +$6.44M

Similar funds

Ardsley Advisory Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Ardsley Advisory Partners held 283 positions worth $631M, down 17% from $759M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ardsley Advisory Partners withdrew a net $128M in Q4 2014, closing 102 positions and reducing 32 holdings. Its most notable exit was Civitas Resources, an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in Community Health Systems worth $17.8M.

  • Ardsley Advisory Partners's largest Q4 2014 buy was Community Health Systems: 399,300 shares worth $17.8M.
  • Ardsley Advisory Partners added most to SolarCity Corporation in Q4 2014, an estimated $13.3M increase.
  • Ardsley Advisory Partners's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $45.2M.
  • Ardsley Advisory Partners fully exited Civitas Resources in Q4 2014, selling an estimated $18.5M.
  • Ardsley Advisory Partners's ten largest holdings make up 38% of its $631M portfolio in Q4 2014.
  • Ardsley Advisory Partners opened 100 new positions and closed 102 in Q4 2014.
  • Ardsley Advisory Partners's portfolio value fell 17% quarter-over-quarter to $631M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2014, filed 17 Feb 2015.